Oncotelic Therapeutics (OTLC) News Today $0.05 +0.00 (+10.26%) As of 11:26 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock OTLC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period IBN Initiates Coverage of Oncotelic Therapeutics Inc.September 10 at 8:30 AM | globenewswire.comDr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving TherapiesSeptember 4, 2025 | financialpost.comFDr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics' Commitment to Innovation, Life-Saving TherapiesSeptember 4, 2025 | globenewswire.comOncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma IndustryAugust 28, 2025 | markets.businessinsider.comOncotelic Therapeutics Showcases Robust Pipeline and Founder's Broad Intellectual Property Contributions to Biopharma IndustryAugust 28, 2025 | globenewswire.comOncotelic Therapeutics Partners with Jefferson and ValorAugust 12, 2025 | msn.comSAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer PatientsJuly 17, 2025 | globenewswire.comOncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer PatientsJuly 17, 2025 | globenewswire.comOncotelic Therapeutics, Inc. (OTLC) - Yahoo FinanceJune 27, 2025 | nz.finance.yahoo.comOncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic CancerJune 25, 2025 | globenewswire.comOncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at IDDST-Europe 2025 Conference in StockholmApril 22, 2025 | globenewswire.comOncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023April 16, 2025 | globenewswire.comOncotelic Therapeutics Inc (OTLC)April 10, 2025 | nasdaq.comOncotelic Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comOncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAIMarch 31, 2025 | globenewswire.comOncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 ConferenceMarch 25, 2025 | globenewswire.comOncotelic Accesses Rapid IND Development Platform through Partnership with MedicilonFebruary 25, 2025 | globenewswire.comOncotelic CEO Vuong Trieu to Present Groundbreaking Research on Transforming Growth Factor Beta 2 (TGFB2) at SWCR 2025 ConferenceFebruary 13, 2025 | globenewswire.comOncotelic Therapeutics Implements PDAOAI PlatformDecember 31, 2024 | globenewswire.comONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024November 6, 2024 | globenewswire.comONCOTELIC PUBLISHED ITS FOURTH PUBLICATION ON TGFB2 THERAPEUTICSOctober 28, 2024 | finance.yahoo.comONCOTELIC PRESENTATION AT PRECISION IN DRUG DISCOVERY & PRECLINICAL SUMMIT SAN DIEGO 2024October 24, 2024 | finance.yahoo.comAlibaba rises on report it will charge software service feeJuly 29, 2024 | uk.finance.yahoo.comProduct Manager Scott Myers to Present at 2nd Global Summit on Artificial IntelligenceJuly 29, 2024 | globenewswire.comONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGYJune 11, 2024 | globenewswire.comONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETINGMay 30, 2024 | globenewswire.comONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETINGMay 20, 2024 | globenewswire.comOncotelic Therapeutics Inc OTLCMay 19, 2024 | morningstar.comMONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024May 16, 2024 | finance.yahoo.comLinkage of Cancer and Lupus in Gliomas PatientsMarch 25, 2024 | finance.yahoo.comLinkage of Cancer and Lupus in Gliomas PatientsMarch 25, 2024 | globenewswire.comInvitation to Participate in STOP-PC Clinical TrialMarch 4, 2024 | globenewswire.comOncotelic Therapeutics Stock (OTC:OTLC) Earnings Dates and Earning CallsFebruary 22, 2024 | benzinga.comOncotelic Therapeutics Strikes Material Definitive Legal AgreementFebruary 3, 2024 | msn.comLineage Cell Therapeutics Inc LCTXJanuary 23, 2024 | morningstar.comMOncotelic Therapeutics Announces Opening of GMP Manufacturing PlantDecember 18, 2023 | finance.yahoo.comOncotelic Therapeutics, Inc.: Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial ResultsNovember 15, 2023 | finanznachrichten.deOncotelic Therapeutics reports Q3 resultsNovember 15, 2023 | msn.comOncotelic Reports Q3 2023 Compared to Q3 2022 Financial ResultsNovember 15, 2023 | finance.yahoo.comThe Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB:OTLC) Is Leading The ChargeSeptember 11, 2023 | benzinga.comThe Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB: OTLC) Is Helping Lead The ChargeSeptember 11, 2023 | benzinga.comOncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023August 25, 2023 | finance.yahoo.comSapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic CancerAugust 23, 2023 | finance.yahoo.comOncotelic Participating at 2023 BIO International ConventionMay 16, 2023 | finance.yahoo.comOncotelic Launches PDAO SEC ChatbotApril 24, 2023 | technews.tmcnet.comOncotelic Therapeutics reports FY resultsApril 19, 2023 | seekingalpha.comOncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model TechnologyApril 19, 2023 | finance.yahoo.comHigh Intra-Tumor TGF-ß2 Predicts Poor Survival in Pediatric Cancer of the BrainstemMarch 13, 2023 | technews.tmcnet.comOTLC Oncotelic Therapeutics, Inc.February 15, 2023 | seekingalpha.comOncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell CancerFebruary 6, 2023 | finance.yahoo.com Get Oncotelic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OTLC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OTLC Media Mentions By Week OTLC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTLC News Sentiment▼0.870.84▲Average Medical News Sentiment OTLC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTLC Articles This Week▼30▲OTLC Articles Average Week Get the Latest News and Ratings for OTLC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ELUT News XTNT News SLGL News ASRT News AVTE News IGMS News PMVP News UNCY News IRD News ARTV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OTLC) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OTLC Stock Alerts